← Back to headlines
ANI Pharmaceuticals Targets Over $1 Billion in 2026 Revenue
ANI Pharmaceuticals aims to achieve over $1 billion in revenue by 2026, focusing on rare disease treatments and expanding its sales force.
27 Feb, 17:58 — 27 Feb, 17:58
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
LTFRB suspends 3 transport network firms for violations
just now
Kerala High Court upholds eviction of Kannur shop tenant, says landlord free to start new business
11m ago
After celebrating its surplus, Hong Kong must work on sustaining it
12m ago
Why the power sector needs a Dangote, by Muyiwa Adetiba
18m ago